Jon Aron Olof Heimer
Vorstandsvorsitzender bei OLINK HOLDING AB
Vermögen: 74 Mio $ am 31.05.2024
Profil
Jon Aron Olof Heimer is currently the Chief Executive Officer & Director at Olink Proteomics AB and the Chief Executive Officer & Director at Olink Holding AB.
He is also the Chairman at Moleculink AB.
Previously, he served as the Chief Executive Officer at OxThera AB and the Chairman at Lumina Adhesives AB.
He was also the Director of Business Development at Q-Med AB and the Director at Q-linea AB from 2018 to 2019.
Additionally, he has held positions as a Director at Bioimics AB and as a Partner at Nexttobe AB.
He completed his undergraduate degree at the University of Uppsala.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
OLINK HOLDING AB
2,61% | 05.02.2024 | 3 103 790 ( 2,61% ) | 74 Mio $ | 31.05.2024 |
Aktive Positionen von Jon Aron Olof Heimer
Unternehmen | Position | Beginn |
---|---|---|
OLINK HOLDING AB | Vorstandsvorsitzender | 01.12.2020 |
Moleculink AB
Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden. | Vorsitzender | - |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Vorstandsvorsitzender | 01.01.2016 |
Ehemalige bekannte Positionen von Jon Aron Olof Heimer
Unternehmen | Position | Ende |
---|---|---|
Q-LINEA AB | Vorsitzender | 01.01.2018 |
Bioimics AB | Direktor/Vorstandsmitglied | - |
Lumina Adhesives AB
Lumina Adhesives AB Industrial SpecialtiesProcess Industries Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden. | Vorsitzender | - |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Corporate Officer/Principal | - |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Corporate Officer/Principal | - |
Ausbildung von Jon Aron Olof Heimer
University of Uppsala | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
Q-LINEA AB | Health Technology |
OLINK HOLDING AB | Health Technology |
Private Unternehmen | 7 |
---|---|
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
Moleculink AB
Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden. | Electronic Technology |
Lumina Adhesives AB
Lumina Adhesives AB Industrial SpecialtiesProcess Industries Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden. | Process Industries |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Nexttobe AB focuses on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. It is a venture capital/private equity firm that invests in technology and consumer companies. The company was founded by Bengt Ågerup in 2011 and is headquartered in Uppsala, Sweden. | Finance |
Bioimics AB | |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Commercial Services |